Diagnosis and treatment of Neisseria gonorrhoeae infections

American Family Physician

Volumn 73, Issue 10, 2006, Pages

  Miller, Karl E ^a,b  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b Department of Family Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; DOXYCYCLINE; LEVOFLOXACIN; METRONIDAZOLE; OFLOXACIN; PROBENECID; QUINOLONE DERIVATIVE;

ANORECTAL DISEASE; ARTICLE; CHLAMYDIASIS; CONJUNCTIVA DISEASE; DYSURIA; EYE DISEASE; GONORRHEA; HUMAN; NEISSERIA GONORRHOEAE; NEISSERIACEAE INFECTION; PELVIS PAIN SYNDROME; PETECHIA; PHARYNX DISEASE; SEXUAL ABUSE; SEXUALLY TRANSMITTED DISEASE; SKIN INFECTION; SYNOVIUM; UROGENITAL SYSTEM; VAGINA DISCHARGE;

ANTI-BACTERIAL AGENTS; FEMALE; FEMALE UROGENITAL DISEASES; GONORRHEA; HUMANS; JOINT DISEASES; MALE; MALE UROGENITAL DISEASES; PELVIC INFLAMMATORY DISEASE; PHARYNGEAL DISEASES; SKIN DISEASES, BACTERIAL;

EID: 33744465221     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Cook RL, Hutchinson SL, Ostergaard L, Braithwaite RS, ness RB. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med 2005;142:914-25.
2. Workowski KA, Levine WC. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002;51(RR-6)1-78. Accessed online September 14, 2005, at: http://www.cdc.gov/ std/treatment/.
3. Koumans EH, Johnson RE, Knapp JS, St Louis ME. Laboratory testing for Neisseria gonorrhoeae by recently introduced nonculture tests: a performance review with clinical and public health considerations. Clin Infect Dis 1998;27:1171-80.
4. Young H, Manavi K, McMillian A. Evaluation of ligase chain reaction for the non-cultural detection of rectal and pharyngeal gonorrhea in men who have sex with men. Sex Transm Infect 2003;79:484-6.
5. Hook EW 3d, Jones RB, Martin DH, Bolan GA, Mroczkowski TF, neumann TM, et al. Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women. Antimicrob Agents Chemother 1993;37:1670-3.
6. Centers for Disease Control and Prevention. Increases in fluoroquinolone-resistant Neisseria gonorrhoeae among men who have sex with men - United States, 2003, and revised recommendations for gonorrhea treatment, 2004. MMWR Morb Mortal Wkly Rep 2004;53:335-8.
7. Fenton KA, Ison C, Johnson AP, Rudd E, Soltani M, Martin I, et al., for the GRASP collaboration. Ciprofloxacin resistance in Neisseria gonorrhoeae in England and Wales in 2002. Lancet 2003;361:1867-9.
8. Sarwal S, Wong T, Sevigny C, ng LK. Increasing incidence of ciprofloxacin-resistant Neisseria gonorrhoeae infection in Canada. CMAJ 2003;168:872-3.
9. Brocklehurst P. Antibiotics for gonorrhoea in pregnancy. Cochrane Database Syst Rev 2002;(2):CD000098.
10. Lyss SB, Kamb ML, Peterman TA, Moran JS, newman DR, Bolan G, et al, for the Project RESPECT Study Group. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med 2003;139:178-85.
11. Kane BG, Degutis LC, Sayward HK, D'Onofrio G. Compliance with the Centers for Disease Control and Prevention recommendations for the diagnosis and treatment of sexually transmitted diseases. Acad Emerg Med 2004;11:371-7.
12. U.S. Preventive Services Task Force. Screening for gonorrhea: recommendation statement. AHRQ Publication no. 05-0579-A. Rockville, Md.: Agency for Healthcare Research and Quality, May 2005. Accessed online June 7, 2005, at: http://www.ahrq.gov/clinic/uspstf05/gonorrhea/gonrs.htm.